Page 1 | Search Results | The Hematologist | American Society of Hematology

Skip Nav Destination

1-20 of 21

Sort by

Sort Order Select

Articles

We Have More in Common Than What Sets Us Apart: Shared Founding Drivers in Myeloid Neoplasms and T-cell Lymphomas

Mark G. Evans, MD, Annette S. Kim, MD, PhD

The Hematologist (2020) 18 (1)

Published: 2020

Articles

Not a oNe TRacK Solid Tumor Mindset Anymore: NTRK Mutations in Hematologic Malignancies

Damodaran Narayanan, MBBS, PhD, Annette S. Kim, MD, PhD

The Hematologist (2020) 17 (6)

Published: 2020

Articles

Long-Term Effects of Donor-derived Clonal Hematopoiesis: The Gift That Keeps on Giving?

Annette S. Kim, MD, PhD

The Hematologist (2020) 17 (5)

Published: 2020

Articles

Unmasking the Immunopathological Characteristics of COVID-19: Monocytes Grow With the Flow and Lymphocytes Shelter in Place?

Daniel DiToro, MD, PhD, Annette S. Kim, MD, PhD

The Hematologist (2020) 17 (4)

https://doi.org/10.1182/hem.V17.4.12884901943

Published: 2020

Articles

Spots and Dots

Olga Pozdnyakova, MD, PhD, Annette S. Kim, MD, PhD

The Hematologist (2020) 17 (4)

https://doi.org/10.1182/hem.V17.4.10411

Published: 2020

Articles

Using Artificial Intelligence to Enhance Diagnosis: Is Resistance Futile?

Annette S. Kim, MD, PhD, Ian Brain, MD

The Hematologist (2020) 17 (3)

https://doi.org/10.1182/hem.V17.3.10379

Published: 2020

Articles

How FLT3-ITDs and NPM1 Insertions Maneuver Into AML Using the Lymphoid Enzyme TdT to Initiate Replication Slippage

Annette S. Kim, MD, PhD, John C. LaMacchia, MD, PhD

The Hematologist (2020) 17 (2)

https://doi.org/10.1182/hem.V17.2.10277

Published: 2020

Articles

Are You a Lumper or a Splitter? Embrace the Genomic Spectrum of Neutrophilic Myeloid Neoplasms

Annette S. Kim, MD, PhD, Christopher B. Hergott, MD, PhD

The Hematologist (2019) 17 (1)

https://doi.org/10.1182/hem.V17.1.10150

Published: 2019

Articles

Primed for Self-Destruction: Adding Venetoclax to Azacitidine for MDS

Annette S. Kim, MD, PhD, Jacqueline S. Garcia, MD, Anthony Letai, MD, PhD

The Hematologist (2019) 16 (6)

Published: 2019

Articles

Primed for Self-Destruction: Adding Venetoclax to Azacitidine for MDS

Annette S. Kim, MD, PhD, Jacqueline S. Garcia, MD, Anthony Letai, MD, PhD

The Hematologist (2019) 16 (6)

https://doi.org/10.1182/hem.V16.6.9942

Published: 2019

Articles

Escape Mechanisms in Allosteric IDH Inhibition

Annette S. Kim, MD, PhD

The Hematologist (2019) 16 (5)

https://doi.org/10.1182/hem.V16.5.9804

Published: 2019

Articles

Seeking Insight Into the AML Subpopulations and Microenvironment Through Single-cell RNA-Seq

Annette S. Kim, MD, PhD

The Hematologist (2019) 16 (4)

https://doi.org/10.1182/hem.V16.4.9644

Published: 2019

Articles

Leukemia Is Exhausting...

Annette S. Kim, MD, PhD

The Hematologist (2019) 16 (3)

https://doi.org/10.1182/hem.V16.3.9554

Published: 2019

Articles

Monitoring Treatment Response in Multiple Myeloma: Wading Into the Deep End

Madhu M. Ouseph, MD, PhD, Annette S. Kim, MD, PhD

The Hematologist (2019) 16 (2)

https://doi.org/10.1182/hem.V16.2.9457

Published: 2019

Articles

Molecular Versus Morphologic Classifications of Myeloproliferative Neoplasms: You Don't Know JAK!

Vignesh Shanmugam, MD, Annette S. Kim, MD, PhD

The Hematologist (2018) 16 (1)

https://doi.org/10.1182/hem.V16.1.9295

Published: 2018

Articles

Bring Novel Agents to the Fore in B-ALL: Adding Inotuzumab to Pediatric-Inspired Regimens for AYAs

Marlise R. Luskin, MD, MSCE, Annette S. Kim, MD, PhD, Daniel J. DeAngelo, MD, PhD

The Hematologist (2018) 15 (6)

https://doi.org/10.1182/hem.V15.6.9041

Published: 2018

Articles

Circulating Tumor DNA in Lymphoma Monitoring: Fantasy, Fad, or Fact?

Annette S. Kim, MD, PhD

The Hematologist (2018) 15 (5)

https://doi.org/10.1182/hem.V15.5.8943

Published: 2018

Articles

The Usual Suspects Aren't Always the Bad Guys! Molecular MRD Comes of Age in AML

Annette S. Kim, MD, PhD

The Hematologist (2018) 15 (4)

https://doi.org/10.1182/hem.V15.4.8685

Published: 2018

Articles

BETting on Targeted Therapy for ASXL1-mutated Myeloid Neoplasms

Annette S. Kim, MD, PhD

The Hematologist (2018) 15 (3)

https://doi.org/10.1182/hem.V15.3.8462

Published: 2018

Articles

A Real Nose-Pincher

Yi Li, MD, MSc, Annette S. Kim, MD, PhD

The Hematologist (2018) 15 (3)

https://doi.org/10.1182/hem.V15.3.8512

Published: 2018

NARROW

We Have More in Common Than What Sets Us Apart: Shared Founding Drivers in Myeloid Neoplasms and T-cell Lymphomas

Not a oNe TRacK Solid Tumor Mindset Anymore: NTRK Mutations in Hematologic Malignancies

Long-Term Effects of Donor-derived Clonal Hematopoiesis: The Gift That Keeps on Giving?

Unmasking the Immunopathological Characteristics of COVID-19: Monocytes Grow With the Flow and Lymphocytes Shelter in Place?

Spots and Dots

Using Artificial Intelligence to Enhance Diagnosis: Is Resistance Futile?

How FLT3-ITDs and NPM1 Insertions Maneuver Into AML Using the Lymphoid Enzyme TdT to Initiate Replication Slippage

Are You a Lumper or a Splitter? Embrace the Genomic Spectrum of Neutrophilic Myeloid Neoplasms

Primed for Self-Destruction: Adding Venetoclax to Azacitidine for MDS

Primed for Self-Destruction: Adding Venetoclax to Azacitidine for MDS

Escape Mechanisms in Allosteric IDH Inhibition

Seeking Insight Into the AML Subpopulations and Microenvironment Through Single-cell RNA-Seq

Leukemia Is Exhausting...

Monitoring Treatment Response in Multiple Myeloma: Wading Into the Deep End

Molecular Versus Morphologic Classifications of Myeloproliferative Neoplasms: You Don't Know JAK!

Bring Novel Agents to the Fore in B-ALL: Adding Inotuzumab to Pediatric-Inspired Regimens for AYAs

Circulating Tumor DNA in Lymphoma Monitoring: Fantasy, Fad, or Fact?

The Usual Suspects Aren't Always the Bad Guys! Molecular MRD Comes of Age in AML

BETting on Targeted Therapy for ASXL1-mutated Myeloid Neoplasms

A Real Nose-Pincher

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only